← Back to Search

Breathing Exercises + Meditation for Glaucoma

N/A
Waitlist Available
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients diagnosed with glaucoma
Patients aged 40-65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit, week 1, week 3, week 6, week 12
Awards & highlights

Study Summary

This trial will study the effects of breathing and meditation on stress levels and quality of life in glaucoma patients. Participants will learn and practice techniques online then answer questionnaires.

Who is the study for?
This trial is for glaucoma patients aged 40-65 who can consent, read English, and have no major mental health issues. They must be able to sit comfortably for half an hour, hear well with closed eyes, and access a computer for virtual sessions.Check my eligibility
What is being tested?
The study tests if breathing exercises followed by meditation can reduce stress and improve life quality in glaucoma patients. Participants will learn these techniques online and practice independently while their results are compared to those receiving usual care.See study design
What are the potential side effects?
Breathing exercises and meditation are generally safe practices with minimal risk of side effects. Some individuals may experience temporary discomfort like lightheadedness or emotional distress during the initial stages of practice.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with glaucoma.
Select...
I am between 40 and 65 years old.
Select...
I can sit comfortably for over 30 minutes without significant pain.
Select...
I can hear well enough to follow spoken directions with my eyes closed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit, week 1, week 3, week 6, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline visit, week 1, week 3, week 6, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Perceived Stress
Change in Quality of Life (QoL)
Change in consideration of future consequences

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Breathing Exercises followed by MeditationExperimental Treatment1 Intervention
Breathing exercises and Meditation taught by Prasanna Wellness, a non-profit organization, helps dissolve stress and create a proper system in the mind. These breathing exercises include slow deep breaths and rapid breaths and are followed by meditation. Participants will receive three weekly online instructions (90 minutes each) by trained instructors in addition to standard care. Weekly 60 minutes follow-ups will include 10 minutes of breathing exercises followed by 33 minutes of guided meditation practice, and then focus on participants' experiences with breathing exercise followed by meditation during the week, additional observations, and a review of relevant knowledge to support their home practice.
Group II: Treatment as UsualActive Control1 Intervention
The usual standard of care for patients with glaucoma includes starting them on first line of drugs. Participants will be initiated and maintained on appropriate dosages of such medications as part of standard of care. The usual standard of care also includes an ophthalmic examination measuring best-corrected Snellen VA and pinhole acuities and a follow-up visit once a year.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,368 Total Patients Enrolled
5 Trials studying Glaucoma
447 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any unreserved vacancies in this clinical trial?

"Clinicaltrials.gov states that this medical study is not presently open for enrollment, despite being first posted on May 1, 2024 and last updated November 16th 2023. Fortunately, there are 611 other trials currently seeking patients to participate in the research."

Answered by AI

Is the current experiment open to participants aged 40 or older?

"In line with the requirements of this research, potential participants must be aged between 40 and 65."

Answered by AI

What are the eligibility requirements for participation in this experiment?

"The criteria for entering this clinical trial are that the patient must have glaucoma and fall within 40-65 years of age. This study is accepting a total of 60 enrollees."

Answered by AI
~40 spots leftby Sep 2025